Semaglutide programs can advertise the same medication name while supplying different services and payment schedules. Start by asking which exact product and form is being proposed, then compare the assessment, medication quantity, delivery and follow-up.
The providers below have full reviews with their current public offer and source links. This list does not establish equivalence between compounded and approved products, and it does not promise a particular treatment result. The individual prescribing decision comes first.
Provider plans and review links
Semaglutide from $79/month; tirzepatide from $129/month
CoreAge Rx provides online assessment for compounded semaglutide and tirzepatide. Compare its starting plan quotes, the amount due and the prescribing decision before enrolling.
At the lowest twelve-month quotes, the corresponding totals are $948 for semaglutide and $1,548 for tirzepatide.
Read CoreAge Rx review →Semaglutide $85/month; tirzepatide $135/month on the linked offer
SuperHealthy Rx advertises compounded semaglutide at $85/month and tirzepatide at $135/month on its linked offer, including the provider visit, medication and shipping.
These figures come from the linked offer, whose headline still refers to a Labor Day promotion. Verify the live checkout price.
Read SuperHealthy Rx review →Semaglutide from $79/month; tirzepatide from $129/month
Likeness Rx offers compounded semaglutide from $79/month and tirzepatide from $129/month, with term-based subscriptions, online provider review and care-team messaging.
The lowest monthly equivalents are $79 and $129 for the twelve-month subscriptions. Check the amount due, selected term and renewal before paying. Twelve-month totals are $948 for semaglutide and $1,548 for tirzepatide.
Read Likeness Rx review →Semaglutide from $96/mo and tirzepatide from $142/mo on 12-month plans, flat at every dose
Ondra Health launched nationwide in May 2026 with compounded semaglutide from $96/month and tirzepatide from $142/month on annual plans, held flat across every dose — and it publicly names all five compounding pharmacies that fill its prescriptions, which no other provider on this list does.
Flat dose pricing means titrating up does not raise your bill.
Read Ondra Health review →Wegovy pill $149/mo, Wegovy pen $199/mo — published per dose
NovoCare Pharmacy is Novo Nordisk's direct-to-patient channel for Wegovy and Ozempic. It publishes flat self-pay pricing — $149/month for the pill forms and $199/month for the pens — which is dramatically below historical list prices.
The 4mg offer at $149 is published as available until August 31, 2026, after which 4mg is $199/month.
Read NovoCare Pharmacy review →Check the exact form and formulation
A compounded semaglutide offer is not an FDA-approved generic. Ask the clinician and dispensing pharmacy to identify the preparation and its instructions. A medication name on a marketing page does not specify the device, concentration or quantity in an individual order.
FDA has raised concerns about unapproved GLP-1 products and dosing errors. If a label or instruction is unclear, contact the pharmacist or prescriber before using the medication. Do not translate another provider’s instructions to a new preparation yourself.
Compare the monthly headline with the charge today
CoreAge’s lowest annual plan quote is $79/month, while its current public semaglutide page advertises $99/month. SuperHealthy’s linked offer advertises $85/month. Likeness displays $79/month for twelve months, billed $948, or $139 for a one-month subscription.
These prices describe different offers and terms. Ask whether the clinician visit, shipping, supplies and dose adjustments are included. A quote should also explain the renewal amount, cancellation process and what happens if treatment is declined or changed.
Plan the questions you may need after delivery
Ask how to reach the prescribing clinician and the dispensing pharmacy. Save both contact routes with the instructions. Confirm how a refill is requested and when a new charge can occur.
Discuss relevant health conditions and current medicines during intake rather than treating a low starting price as a suitability test. If you have already used another GLP-1 product, tell the clinician which preparation and instructions you have; they decide how treatment should continue.
Sources and next reading
Provider offers were checked October 4, 2026. Each full review links its product and pricing sources and records details that still need confirmation.
FDA: risks of compounded drugs
FDA: concerns with unapproved GLP-1 drugs
All provider reviews · Complete provider comparison
Medical Disclaimer
We're not doctors, and this article is for education only — it isn't medical advice. GLP-1 medications are prescription-only and require evaluation by a licensed healthcare provider. Individual results vary widely, and only a clinician who knows your history can determine what is safe and appropriate for you. See our full medical disclaimer.
Keep Comparing
Every provider we've researched, with published pricing, medication type, and what's actually included.
Affiliate Disclosure: This article may contain affiliate links. If you sign up through one, we may earn a commission at no additional cost to you. We do not accept payment for favorable coverage. Read our full affiliate disclosure policy.